Literature DB >> 16751372

IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation.

Nathalie E Blachère1, Heather K Morris, Deborah Braun, Hélène Saklani, James P Di Santo, Robert B Darnell, Matthew L Albert.   

Abstract

Dendritic cells (DCs) are capable of capturing exogenous Ag for the generation of MHC class I/peptide complexes. For efficient activation of memory CD8(+) T cells to occur via a cross-presentation pathway, DCs must receive helper signals from CD4(+) T cells. Using an in vitro system that reflects physiologic recall memory responses, we have evaluated signals that influence helper-dependent cross-priming, while focusing on the source and cellular target of such effector molecules. Concerning the interaction between CD4(+) T cells and DCs, we tested the hypothesis that CD40 engagement on DCs is critical for IL-12p70 (IL-12) production and subsequent stimulation of IFN-gamma release by CD8(+) T cells. Although CD40 engagement on DCs, or addition of exogenous IL-12 are both sufficient to overcome the lack of help, neither is essential. We next evaluated cytokines and chemokines produced during CD4(+) T cell/DC cross talk and observed high levels of IL-2 produced within the first 18-24 h of Ag-specific T cell engagement. Functional studies using blocking Abs to CD25 completely abrogated IFN-gamma production by the CD8(+) T cells. Although required, addition of exogenous IL-2 did not itself confer signals sufficient to overcome the lack of CD4(+) T cell help. Thus, these data support a combined role for Ag-specific, cognate interactions at the CD4(+) T cell/DC as well as the DC/CD8(+) T cell interface, with the helper effect mediated by soluble noncognate signals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751372     DOI: 10.4049/jimmunol.176.12.7288

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Signal 0 for guided priming of CTLs: NKT cells do it too.

Authors:  Philippe Bousso; Matthew L Albert
Journal:  Nat Immunol       Date:  2010-04       Impact factor: 25.606

Review 2.  The potential of CD4 T-cell memory.

Authors:  K Kai McKinstry; Tara M Strutt; Susan L Swain
Journal:  Immunology       Date:  2010-03-16       Impact factor: 7.397

3.  CD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses.

Authors:  Joshua J Obar; Michael J Molloy; Evan R Jellison; Thomas A Stoklasek; Weijun Zhang; Edward J Usherwood; Leo Lefrançois
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

4.  An artificial antigen-presenting cell with paracrine delivery of IL-2 impacts the magnitude and direction of the T cell response.

Authors:  Erin R Steenblock; Tarek Fadel; Michael Labowsky; Jordan S Pober; Tarek M Fahmy
Journal:  J Biol Chem       Date:  2011-08-17       Impact factor: 5.157

5.  Intradermal Immunization with rAAV1 Vector Induces Robust Memory CD8+ T Cell Responses Independently of Transgene Expression in DCs.

Authors:  Alexandre Ghenassia; David-Alexandre Gross; Stéphanie Lorain; Fabiola Tros; Dominique Urbain; Sofia Benkhelifa-Ziyyat; Alain Charbit; Jean Davoust; Pascal Chappert
Journal:  Mol Ther       Date:  2017-07-15       Impact factor: 11.454

6.  Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer model.

Authors:  Yohei Mineharu; A K M Ghulam Muhammad; Kader Yagiz; Marianela Candolfi; Kurt M Kroeger; Weidong Xiong; Mariana Puntel; Chunyan Liu; Eva Levy; Claudia Lugo; Adrina Kocharian; James P Allison; Michael A Curran; Pedro R Lowenstein; Maria G Castro
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

7.  T cells presenting viral antigens or autoantigens induce cytotoxic T cell anergy.

Authors:  Nathalie E Blachère; Dana E Orange; Emily C Gantman; Bianca D Santomasso; Graeme C Couture; Teresa Ramirez-Montagut; John Fak; Kevin J O'Donovan; Zhong Ru; Salina Parveen; Mayu O Frank; Michael J Moore; Robert B Darnell
Journal:  JCI Insight       Date:  2017-11-02

8.  Repeated Injections of IL-2 Break Renal Allograft Tolerance Induced via Mixed Hematopoietic Chimerism in Monkeys.

Authors:  Y Yamada; O Nadazdin; S Boskovic; S Lee; E Zorn; R N Smith; R B Colvin; J C Madsen; A B Cosimi; T Kawai; G Benichou
Journal:  Am J Transplant       Date:  2015-07-17       Impact factor: 8.086

9.  Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.

Authors:  Marina Zafranskaya; Patrick Oschmann; Rosel Engel; Andreas Weishaupt; Johannes M van Noort; Hassan Jomaa; Matthias Eberl
Journal:  Immunology       Date:  2006-12-18       Impact factor: 7.397

10.  Preferential benefit of antibody induction therapy in kidney recipients with high pretransplant frequencies of donor-reactive interferon-gamma enzyme-linked immunosorbent spots.

Authors:  Joshua J Augustine; Emilio D Poggio; Peter S Heeger; Donald E Hricik
Journal:  Transplantation       Date:  2008-08-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.